Author Archives: Megan Thomas

Paris
#Cell and gene therapy #Events #ISCT #new generation MSCs

ISCT 2023 key trends: redefining manufacturing 

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France from… Read More

#Exclusive Content #Regulatory

#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Meet the researcher: Vito Palombella, Surface Oncology 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Vito Palombella, Chief Scientific Officer at Surface Oncology.  MT: Where do you work, and… Read More

#Cancer Research #Exclusive Content #Opinion

#AACR 2023 #Cancer research #DDW Events podcast #Meet the Researcher #Oncology #Surface Oncology

Don’t miss AACR 2023 on the DDW Events podcast 

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, which took place in April 2023, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research, who you will hear from across three episodes of the… Read More

#Cancer Research #News #Opinion

#Drug development #Drug discovery #Life science #Partnership #Pistoia Alliance

Pistoia Alliance announces Japanese R&D partnerships 

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK to enable pre-competitive collaboration in the Japanese market.   The Alliance and Matador share the vision that bringing together experts from diverse backgrounds… Read More

#News

Cancer cell
#AACR 2023 #Cancer research #CAR-T #DDW Events podcast #Meet the Researcher #T cell receptor (TCR) #Triumvira Immunologics

DDW Events: AACR 2023 Episode 3 with Vito Palombella, Surface Oncology

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. In this latest episode, Thomas speaks with Vito Palombella, Chief Scientific Officer at Surface Oncology. You… Read More

#Podcasts

AI brain partnership
#ACROBiosystems #Diagnostics #Electrophysiology #In vivo #Neuroscience #Partnership

Partnership to accelerate neuroscience drug discovery  

ACROBiosystems, through ACRO Certify and under its Aneuro brand, has launched in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips.   Together, the two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialisation.  Electrophysiology is a critical part… Read More

#News

Paris
#Advanced Therapies #Cell and gene therapy #ISCT #Regulatory

ISCT 2023 key trends: regulatory changes 

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France from… Read More

#Exclusive Content #Regulatory

Blood donor day
#Blood bank #Blood donation #Blood Donor Day 2023

Blood Donor Day 2023: The importance for new therapies

Blood Donor Day, an annual event on June 14, was organised for the first time in 2004 by four core international organisations: the World Health Organization, the International Federation of Red Cross and Red Crescent Societies; the International Federation of Blood Donor Organizations (IFBDO) and the International Society of Blood… Read More

#Exclusive Content

#Contract Research Organisations (CROs) #Digitalisation #Proscia #Research #Therapeutics

Key findings from life sciences digital pathology adoption survey 

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. Over half of these organisations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of… Read More

#Editor's Choice #News

Respiratory syncytial virus
#FDA #GSK #Immunology / Virology & Vaccines #Pfizer #Respiratory syncytial virus

GSK faces RSV vaccine threat from rival Pfizer  

An FDA approval for Pfizer’s Abrysvo respiratory syncytial virus (RSV) vaccine is likely to threaten GSK’s current hold on the market, according to GlobalData.  GSK received approval by the European Commision (EC) for its vaccine Arexvy, which targets the prevention of lower respiratory tract infections (LRTI) caused by RSV in… Read More

#News #Regulatory #Trending News

Cancer cells
#American Society of Clinical Oncology #Breast cancer #Cancer research #HER2 #Oncology #The College of American Pathologists

Updates to HER2 testing guidelines reduces confusion 

The College of American Pathologists (CAP) and American Society of Clinical Oncology (ASCO) have reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.  The recent clinical trial for metastatic breast cancer patients (DESTINY-Breast04) found that a treatment traditionally… Read More

#Cancer Research #News #Regulatory #Trending News

#AACR 2023 #Cancer research #CAR-T #DDW Events podcast #Meet the Researcher #T cell receptor (TCR) #Triumvira Immunologics

Meet the researcher: Andreas Bader, Triumvira Immunologics

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW's Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. Thomas speaks with Andreas Bader, Chief Scientific Officer at Triumvira Immunologics. MT: Where do you work, and… Read More

#Cancer Research #Exclusive Content #Opinion

Cancer cells
#AACR 2023 #Cancer research #CAR-T #DDW Events podcast #Meet the Researcher #T cell receptor (TCR) #Triumvira Immunologics

DDW Events: AACR 2023 Episode 2 with Andreas Bader, Triumvira Immunologics

At the American Association of Cancer Research’s Annual Meeting in Orlando, Florida, DDW’s Megan Thomas met with industry experts to learn more about their research and careers in the field of cancer research. In this latest episode, Thomas speaks with Andreas Bader, Chief Scientific Officer at Triumvira Immunologics. You… Read More

#Podcasts

Cancer cell
#Cancer research #Chemotherapy #Drug development #National Institute for Health and Care Excellence (NICE) #Regulatory

Positive NICE recommendation for BRCAm ovarian cancer 

AstraZeneca UK announced that Lynparza (olaparib) is recommended by the National Institute for Health and Care Excellence (NICE) for maintenance treatment of BRCA-mutated relapsed, platinum-sensitive, high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer in adults who have had two or more courses of platinum-based chemotherapy.  BRCA1 and BRCA2 are… Read More

#Editor's Choice #News #Regulatory #Trending News

Paris
#Cell and gene therapy #Events #ISCT #Mesenchymal stem cells #new generation MSCs

ISCT 2023 key trends: new generation MSCs  

The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared mission to drive the translation of all cell and gene (CGT) therapies for the benefit of patients worldwide. The ISCT 2023 Annual Meeting took place in Paris, France from… Read More

#Exclusive Content